Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?

Acta Oto-Laryngologica

Volumn 126, Issue 11, 2006, Pages 1225-1228

  Dequanter, Didier ^a   Lothaire, Philippe ^a   Awada, Ahmad ^a   Lalami, Yassine ^a   Nguyen, Thi Hien ^a   Lemort, Marc ^a   Vandevelde, Luc ^a   Andry, Guy ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Chemoradiotherapy; Clinical response; Head and neck cancer; N2 N3 neck disease; Neck dissection; Radiological response

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PREDICTION; PRIORITY JOURNAL; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; RADIOISOTOPE TELETHERAPY; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750055262     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600818088     Document Type: Article

References (12)

1. Ampil F, Mills GM, Caldito G, Burton GV, Nathan CA, Aarstad RF, et al. Induction chemotherapy followed by concomitant chemoradiation induced regression of advanced cervical lymphadenectomy in head and neck cancer as a predictor outcome. Otolaryngol Head Neck Surg 2002;126: 602-6.
2. Argiris A, Stenson KM, Brockstein BE, Mittakl BB, Pelzer H, Kies MS, et al. Neck dissection in the combined modality therapy of patients with locoregionally head and neck cancer. Head Neck 2004;26:447-55.
3. Brizel DM, Prosnitz RG, Hunter S, Fischer SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-23.
4. Johnson CR, Silverman LN, Clay LB, Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is post radiotherapy neck dissection necessary? Radiat Oncol Invest 1998;6:52-7.
5. McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, et al. Who merits a neck dissection after definitive chemoradioterapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25: 791-8.
6. Grabenbauer G, Rödel C, Ernst-Stecken A, Brunner T, Hornung J, Kittel K, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only? Radiother Oncol 2003;66:57-63.
7. Leon X, Quer M, Orus C, de Dios E, Recher K. Treatment of neck nodes after induction chemotherapy in patients with primary advanced tumours. Eur Arch Otorhinolaryngol 2000;237:521-5.
8. Wolf G, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-9.
9. Sanguineti G, Corvo R, Benasso M, Marganiro G, Sormani MP, Roncallo F, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21:223-8.
10. Stenson KM, Haraf DJ, Pelzer H, Recant W, Kies MS, Weichselbaum RR, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2000;126:950-6.
11. Newman JP, Fee We, Terris DJ, Goode RL, Pinto HA, Goffinet DR. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 1997;106:117-22.
12. Lavertu P, Bonafede JP, Adelstein DJ, Saxton JP, Strome M, Wanamaker JR, et al. Comparison of surgical complications after organ preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-6.